AXIM Biotechnologies, Inc. announced it has entered into Purchase Agreement and issued unsecured convertible promissory notes for a gross proceeds of $814,555 on March 15, 2024. The number of shares of Common Stock into which this Note may be converted shall be determined by dividing the aggregate principal amount being tendered for conversion including interest accrued thereon by the Conversion Price in effect at the time of such conversion. The initial Conversion Price shall be equal to $0.01.The Notes pay annual interest at the rate of 4.25% annually which shall accrue until the maturity date of March 1, 2034, at which time all principal and interest accrued thereon shall be due and payable.